Suzhou, China

Fan Hu

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Sinovent Pharmaceuticals Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fan Hu. Retrieved from https://idiyas.com/inventor/fan-hu-nv438ztf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fan Hu - Innovator in Pharmaceutical Chemistry

Introduction

Fan Hu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of heterocyclic compounds.

Latest Patents

Fan Hu holds a patent for a heterocyclic compound, which includes its application and a pharmaceutical composition comprising the same. The invention discloses a heterocyclic compound represented by a specific formula or a pharmaceutically acceptable salt thereof. This compound exhibits a novel structure and demonstrates good inhibitory activity against autotaxin (ATX). His patent is a testament to his expertise and dedication to advancing pharmaceutical science.

Career Highlights

Fan Hu is associated with Suzhou Sinovent Pharmaceuticals Co., Ltd., where he applies his knowledge and skills to develop innovative pharmaceutical solutions. His work has been instrumental in enhancing the understanding and application of heterocyclic compounds in medicine.

Collaborations

Fan Hu collaborates with talented professionals in his field, including Yonghan Hu and Dongdong Wu. These collaborations foster a dynamic environment for innovation and research.

Conclusion

Fan Hu's contributions to pharmaceutical chemistry, particularly through his patent on heterocyclic compounds, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…